Drug: emend Quarter: 2016Q3
Total Records: 233 Number of Pages: 12
DRUGNAME | PT | EventCount |
---|---|---|
EMEND | Infusion site streaking | 2 |
EMEND | Intentional product misuse | 2 |
EMEND | Malignant neoplasm progression | 2 |
EMEND | Migraine | 2 |
EMEND | Nervousness | 2 |
EMEND | Neuralgia | 2 |
EMEND | Oesophagitis | 2 |
EMEND | Pain | 2 |
EMEND | Palmar-plantar erythrodysaesthesia syndrome | 2 |
EMEND | Pancreatitis | 2 |
EMEND | Pancytopenia | 2 |
EMEND | Peripheral swelling | 2 |
EMEND | Petit mal epilepsy | 2 |
EMEND | pH urine decreased | 2 |
EMEND | pH urine increased | 2 |
EMEND | Pruritus | 2 |
EMEND | Skin irritation | 2 |
EMEND | Upper respiratory tract infection | 2 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Adverse event | 2 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Colitis | 2 |
Total Records: 233 Number of Pages: 12